Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Shares Issued (2021 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Shares Issued for 8 consecutive years, with $174375.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued changed N/A year-over-year to $174375.0, compared with a TTM value of -$4.4 million through Dec 2025, changed N/A, and an annual FY2025 reading of $69750.0, down 91.66% over the prior year.
  • Shares Issued was $174375.0 for Q4 2025 at Neuroone Medical Technologies, up from -$9.5 million in the prior quarter.
  • Across five years, Shares Issued topped out at $9.2 million in Q2 2025 and bottomed at -$9.5 million in Q3 2025.
  • Average Shares Issued over 4 years is -$205059.5, with a median of $219614.5 recorded in 2021.
  • Peak annual rise in Shares Issued hit 446.5% in 2025, while the deepest fall reached 127.4% in 2025.
  • Year by year, Shares Issued stood at -$1.3 million in 2021, then soared by 194.67% to $1.3 million in 2023, then crashed by 434.09% to -$4.2 million in 2024, then soared by 104.15% to $174375.0 in 2025.
  • Business Quant data shows Shares Issued for NMTC at $174375.0 in Q4 2025, -$9.5 million in Q3 2025, and $9.2 million in Q2 2025.